Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer

NCT00322400 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Recurrent and Metastatic Breast Cancer

Interventions

DRUG: Docetaxel
DRUG: Paclitaxel
DRUG: AMG 706

Sponsor

Amgen